Oncogenesis - Table of Contents alert Volume 6, April 2017

Advertisement IMMUNE PROFILING IN HEALTH AND DISEASE  September 17-19, 2017 | Seattle, WA, USA Presented by: Adaptive Biotechnologies | Nature Immunology | Nature Medicine | Nature Biotechnology REGISTER NOW! TABLE OF CONTENTS Volume 6, April 2017 In this issue Review Original Articles Short Communication Corrigenda Advertisement BIOPHARMA DEALMAKERS - March issue A supplement to Nature Biotechnology | Nature Reviews Drug Discovery Check out the latest issue of BioPharma Dealmakers for the latest dealmaking opportunities, and editorials on personalized cancer vaccines based on tumor-specific neoantigens, the expanding network of microbiome partnerships, and impending growth spurt of the dermatology market. Download the issue for FREE Sign up for e-alerts Web feed Review Top Wnt signaling in triple-negative breast cancer SÖ-G Pohl, N Brook, M Agostino, F Arfuso, A P Kumar and A Dharmarajan Oncogenesis 2017 6: e310; 10.1038/oncsis.2017.14 Abstract | Full Text Original Articles Top Initial sites of hepadnavirus integration into host genome in human hepatocytes and in the woodchuck model of hepatitis B-associated hepatocellular carcinoma R Chauhan, N D Churchill, P M Mulrooney-Cousins and T I Michalak Oncogenesis 2017 6: e317; 10.1038/oncsis.2017.22 Abstract | Full Text MET amplification and epithelial-to-mesenchymal transition exist as parallel resistance mechanisms in erlotinib-resistant, EGFR-mutated, NSCLC HCC827 cells K R Jakobsen, C Demuth, A T Madsen, D Hussmann, J Vad-Nielsen, A L Nielsen and B S Sorensen Oncogenesis 2017 6: e307; 10.1038/oncsis.2017.17 Abstract | Full Text MAGE-TRIM28 complex promotes the Warburg effect and hepatocellular carcinoma progression by targeting FBP1 for degradation X Jin, Y Pan, L Wang, L Zhang, R Ravichandran, P R Potts, J Jiang, H Wu and H Huang Oncogenesis 2017 6: e312; 10.1038/oncsis.2017.21 Abstract | Full Text Methylation of WNT target genes AXIN2 and DKK1 as robust biomarkers for recurrence prediction in stage II colon cancer R Kandimalla, J F Linnekamp, S van Hooff, A Castells, X Llor, M Andreu, R Jover, A Goel and J P Medema Oncogenesis 2017 6: e308; 10.1038/oncsis.2017.9 Abstract | Full Text Inhibition of DNA2 nuclease as a therapeutic strategy targeting replication stress in cancer cells S Kumar, X Peng, J Daley, L Yang, J Shen, N Nguyen, G Bae, H Niu, Y Peng, H-J Hsieh, L Wang, C Rao, C C Stephan, P Sung, G Ira and G Peng Oncogenesis 2017 6: e319; 10.1038/oncsis.2017.15 Abstract | Full Text CRB3 downregulation confers breast cancer stem cell traits through TAZ/β-catenin P Li, Y Wang, X Mao, Y Jiang, J Liu, J Li, J Wang, R Wang, J She, J Zhang, J Yang, Y Liu and P Liu Oncogenesis 2017 6: e322; 10.1038/oncsis.2017.24 Abstract | Full Text p16 controls epithelial cell growth and suppresses carcinogenesis through mechanisms that do not require RB1 function M Sen, N Akeno, A Reece, A L Miller, D S Simpson and K A Wikenheiser-Brokamp Oncogenesis 2017 6: e320; 10.1038/oncsis.2017.5 Abstract | Full Text Oncogenic MCT-1 activation promotes YY1-EGFR-MnSOD signaling and tumor progression H-Y Tseng, Y-A Chen, J Jen, P-C Shen, L-M Chen, T-D Lin, Y-C Wang and H-L Hsu Oncogenesis 2017 6: e313; 10.1038/oncsis.2017.13 Abstract | Full Text Loss of LZAP inactivates p53 and regulates sensitivity of cells to DNA damage in a p53-dependent manner J J Wamsley, C Gary, A Biktasova, M Hajek, G Bellinger, R Virk, N Issaeva and W G Yarbrough Oncogenesis 2017 6: e314; 10.1038/oncsis.2017.12 Abstract | Full Text TCRP1 promotes NIH/3T3 cell transformation by over-activating PDK1 and AKT1 C Wang, H Liu, Q Qiu, Z Zhang, Y Gu and Z He Oncogenesis 2017 6: e323; 10.1038/oncsis.2017.18 Abstract | Full Text The pleiotropic regulation of cyclin D1 by newly identified sesaminol-binding protein ANT2 M Watanabe, Y Iizumi, M Sukeno, M Iizuka-Ohashi, Y Sowa and T Sakai Oncogenesis 2017 6: e311; 10.1038/oncsis.2017.10 Abstract | Full Text Twist1/Dnmt3a and miR186 establish a regulatory circuit that controls inflammation-associated prostate cancer progression X Zhao, R Deng, Y Wang, H Zhang, J Dou, L Li, Y Du, R Chen, J Cheng and J Yu Oncogenesis 2017 6: e315; 10.1038/oncsis.2017.16 Abstract | Full Text Short Communication Top p53 targets TSPAN8 to prevent invasion in melanoma cells G Agaësse, L Barbollat-Boutrand, M El Kharbili, O Berthier-Vergnes and I Masse Oncogenesis 2017 6: e309; 10.1038/oncsis.2017.11 Abstract | Full Text Corrigenda Top A natural food sweetener with anti-pancreatic cancer properties C Liu, L-H Dai, D-Q Dou, L-Q Ma and Y-X Sun Oncogenesis 2017 6: e316; 10.1038/oncsis.2017.19 Full Text MiR-186 inhibited aerobic glycolysis in gastric cancer via HIF-1α regulation L Liu, Y Wang, R Bai, K Yang and Z Tian Oncogenesis 2017 6: e318; 10.1038/oncsis.2017.20 Full Text Advertisement An online-only, open access, multidisciplinary journal dedicated to publishing high-quality original research articles, reviews, editorials, commentaries, and hypothesis generating observations on all areas of breast cancer research. Part of the Nature Partner Journals series, published in partnership with the Breast Cancer Research Foundation.  Now open for submissions >>  Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogenesis. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.